InfuSystem Holdings (INFU) Accounts Payables (2010 - 2026)
InfuSystem Holdings (INFU) posted Accounts Payables of $9.6 million for Q1 2026, down 10.99% on a QoQ basis from $10.8 million in Q4 2025, and up 15.12% year-over-year from $8.4 million in Q1 2025.
InfuSystem Holdings (INFU) Accounts Payables (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Accounts Payables history runs 17 years deep, the most recent figure standing at $9.6 million for Q1 2026.
- Quarterly Accounts Payables rose 15.12% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 15.12% YoY) and the FY2025 annual result came in at $10.8 million, up 9.88% from the prior year.
- Accounts Payables was $9.6 million for Q1 2026 at InfuSystem Holdings, down from $10.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $10.8 million in Q4 2025 and bottomed at $5.5 million in Q2 2023.
- A 5-year average of $8.7 million and a median of $8.9 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables slumped 41.9% — and 2024, when it soared 81.35%.
- InfuSystem Holdings' Accounts Payables stood at $8.3 million in 2022, then decreased by 3.98% to $8.0 million in 2023, then grew by 22.96% to $9.8 million in 2024, then grew by 9.88% to $10.8 million in 2025, then dropped by 10.99% to $9.6 million in 2026.
- Business Quant data shows INFU's Accounts Payables at $9.6 million in Q1 2026, $10.8 million in Q4 2025, and $10.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.63 Mn |
| Dec 31, 2025 | 10.82 Mn |
| Sep 30, 2025 | 10.02 Mn |
| Jun 30, 2025 | 9.32 Mn |
| Mar 31, 2025 | 8.37 Mn |
| Dec 31, 2024 | 9.85 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Jun 30, 2024 | 9.94 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.63 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Mar 31, 2023 | 7.37 Mn |
| Dec 31, 2022 | 8.34 Mn |
| Sep 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 9.43 Mn |
| Mar 31, 2022 | 8.24 Mn |
| Dec 31, 2021 | 7.86 Mn |
| Sep 30, 2021 | 6.70 Mn |
| Jun 30, 2021 | 7.80 Mn |